VIDA Ventures is a venture capital firm focused on biomedical innovations.

VIDA Ventures

Vida Ventures is a next-generation life sciences investment firm founded in 2017 by a group of scientists, physicians, entrepreneurs and investors passionate about building and funding breakthroughs in biomedicine. Together we form an independent, bold investment group bound together by a simple word – life. Our mission is to bring science to life and advance transformative biomedical innovations that have the potential to make a meaningful difference for patients. Vida has a bicoastal presence and currently manages approximately $1.8 billion.

LianBio

Dyne Therapeutics

Allogene Therapeutics

Neogene Therapeutics

Oyster Point Pharmaceuticals

Praxis Precision Medicines

Asklepios BioPharmaceutical

Centessa Pharmaceuticals

Homology Medicines

Kinnate Biopharma

Sutro Biopharma

Vigil Neuroscience

Kronos Bio

Vida Ventures, LLC

Tectonic Therapeutic, Inc. is now a public company (Nasdaq: TECX)! An important milestone on their way to advancing biologics that overcome the existing challenges of GPCR-targeted drug discovery. Learn more: https://bwnews.pr/4exzhW4 #VidaPortfolio

Today, Vigil Neuroscience announced a $40 Million strategic investment from Sanofi, further validating Vigil’s promising precision medicine approach. Congratulations, Vigil team! Learn more: https://bit.ly/4cmjyrm #VidaPortfolio #VIGL

Proud to co-lead InduPro’s $85 million Series A financing as they leverage induced proximity to modulate disease biology towards next-generation therapeutics. This financing will enable the company to further refine the technology and to map and drug protein interactions in cancer and autoimmune disease. Congratulations, InduPro! Read more: https://bit.ly/3L2r7aR #VidaPortfolio

For the 9th straight year, Los Angeles Business Journal has recognized our Co-Founder and Senior Managing Director, Arie Belldegrun, MD, in the #LA500, a list that celebrates notable entrepreneurs and executives who influence Los Angeles. Arie’s visionary leadership, creativity and commitment continues to shape LA’s growing life sciences ecosystem. Congratulations on this well-deserved recognition! Learn more: https://bit.ly/3wS93wF

The Vida Ventures, LLC Boston team hosted a mixer for members of the Harvard Biotech Club yesterday, giving students an opportunity to learn more about the firm, valuable insights on life sciences investing and meet professionals in their field. Special thank you to our crimson alumns, Jill Goldstein, Mark Springel, Stefan Vitorovic and Arjun Goyal, M.D. for the photos. 
 
Thanks GSAS Harvard Biotech Club for stopping by!

Today, Aktis Oncology announced their collaboration with Eli Lilly and Company, leveraging Aktis’ proprietary miniprotein
discovery platform and Lily’s expertise to generate novel tumor-targeting
radiopharmaceuticals for cancer patients. Congratulations, Aktis, on this exciting milestone! Learn more: http://bit.ly/4bR83rr #VidaPortfolio

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jul 11, 2024 10:40 PM	a39dc344
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jul 12, 2024 6:44 AM	33390e8c
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jul 11, 2024 10:40 PM	64b0446a
translate crunchbase fundingrounds	general
peers	general	Jul 11, 2024 10:40 PM	215fb035
news basic	general	Jul 11, 2024 10:40 PM	4348da0b
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

VIDA

COM:VIDAVENTURES

VIDA Ventures